Free Trial

Swiss National Bank Has $29.24 Million Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

→ What’s Pelosi Buying Now? (From Altimetry) (Ad)
Bath & Body Works logo with Retail/Wholesale background

Swiss National Bank trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 677,400 shares of the company's stock after selling 22,200 shares during the period. Swiss National Bank owned about 0.30% of Bath & Body Works worth $29,237,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of BBWI. Darsana Capital Partners LP acquired a new stake in Bath & Body Works in the 3rd quarter valued at $76,050,000. Earnest Partners LLC lifted its position in Bath & Body Works by 1,055,015.7% during the 3rd quarter. Earnest Partners LLC now owns 1,276,690 shares of the company's stock worth $43,152,000 after acquiring an additional 1,276,569 shares in the last quarter. Newport Trust Company LLC purchased a new position in Bath & Body Works in the 3rd quarter worth approximately $24,721,000. Victory Capital Management Inc. grew its position in Bath & Body Works by 339.0% in the third quarter. Victory Capital Management Inc. now owns 638,806 shares of the company's stock valued at $21,592,000 after acquiring an additional 493,297 shares in the last quarter. Finally, Sound Shore Management Inc CT purchased a new stake in shares of Bath & Body Works during the third quarter valued at approximately $13,424,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of recent analyst reports. Evercore ISI boosted their price objective on shares of Bath & Body Works from $30.00 to $45.00 and gave the stock an "in-line" rating in a report on Friday, March 1st. BMO Capital Markets lifted their price objective on Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. Wells Fargo & Company raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 24th. Piper Sandler increased their price objective on shares of Bath & Body Works from $44.00 to $45.00 and gave the company a "neutral" rating in a research note on Tuesday, April 9th. Finally, TD Cowen upped their target price on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an "outperform" rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $46.73.


Read Our Latest Analysis on Bath & Body Works

Bath & Body Works Trading Up 2.0 %

BBWI traded up $0.94 during trading hours on Thursday, hitting $48.56. The company's stock had a trading volume of 2,041,390 shares, compared to its average volume of 2,727,121. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The company has a 50-day simple moving average of $46.07 and a 200 day simple moving average of $41.43. The firm has a market capitalization of $10.92 billion, a PE ratio of 12.37, a PEG ratio of 1.49 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.21. The business had revenue of $2.91 billion for the quarter, compared to analysts' expectations of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company's revenue was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $1.86 earnings per share. Research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works's dividend payout ratio is presently 20.78%.

Insider Activity at Bath & Body Works

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the company's stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares of the company's stock, valued at approximately $2,248,548.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.19% of the company's stock.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

→ How Biden has already won 2024 (From Porter & Company) (Ad)

Should you invest $1,000 in Bath & Body Works right now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Recent Videos

Profit Like Congress: The Stocks They’re Betting On
Cathie Wood’s AMD Buy: Smart Move or Risky Business
4 of the Best Stocks for Share Buybacks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines